J W Jukema Selected Research

Stents

10/2018	Appropriate use criteria for optical coherence tomography guidance in percutaneous coronary interventions : Recommendations of the working group of interventional cardiology of the Netherlands Society of Cardiology.
12/2017	Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention or after acute coronary syndrome : Practical lessons from a review.
2/2016	Treatment variation in stent choice in patients with stable or unstable coronary artery disease.
2/2008	Dexamethasone-eluting stents for the prevention of in-stent restenosis: evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patients.
4/2000	Clinical and angiographic outcome of stent implantation without predilatation using the Jostent Flex stent.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J W Jukema Research Topics

Disease

25	Atherosclerosis 01/2021 - 03/2000
21	Cardiovascular Diseases (Cardiovascular Disease) 05/2022 - 10/2000
20	Coronary Artery Disease (Coronary Atherosclerosis) 09/2017 - 03/2000
9	Inflammation (Inflammations) 01/2021 - 01/2007
6	Myocardial Infarction 11/2020 - 04/2001
6	Atherosclerotic Plaque (Atheroma) 04/2017 - 10/2001
5	Pathologic Constriction (Stenosis) 01/2022 - 04/2000
5	Obesity 01/2021 - 11/2007
4	Thrombosis (Thrombus) 10/2018 - 01/2007
4	Coronary Disease (Coronary Heart Disease) 02/2008 - 07/2003
4	Rupture 01/2007 - 04/2001
3	Ischemia 01/2022 - 10/2007
3	Acute Coronary Syndrome 11/2020 - 12/2008
3	Muscular Diseases (Myopathy) 06/2012 - 07/2003
2	Hemorrhage 11/2020 - 02/2006
2	Heart Failure 01/2020 - 01/2018
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018 - 12/2012
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 02/2015
2	Diabetes Mellitus 09/2017 - 02/2008
2	Hypertension (High Blood Pressure) 04/2016 - 09/2010
2	Overweight 01/2016 - 11/2007
2	Vascular Remodeling 04/2012 - 10/2000
2	Stroke (Strokes) 02/2009 - 08/2008
2	Type 2 Diabetes Mellitus (MODY) 09/2008 - 03/2008
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2008 - 08/2006
2	Weight Loss (Weight Reduction) 11/2007 - 07/2003
1	Chest Pain (Chest Pains) 01/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 11/2021
1	Death (Near-Death Experience) 06/2021
1	Anemia 11/2020
1	Non-ST Elevated Myocardial Infarction 11/2020
1	Fibrosis (Cirrhosis) 06/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Hypothyroidism 09/2018
1	Spontaneous Abortion (Miscarriage) 01/2018
1	Habitual Abortion (Recurrent Miscarriage) 01/2018
1	Albuminuria 01/2018

Drug/Important Bio-Agent (IBA)

10	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2016 - 10/2000
9	HDL CholesterolIBA 05/2008 - 03/2001
8	LipidsIBA 01/2020 - 03/2000
7	Pravastatin (Pravachol)FDA LinkGeneric 04/2016 - 10/2000
6	CholesterolIBA 01/2020 - 04/2001
5	Triglycerides (Triacylglycerol)IBA 01/2020 - 10/2000
5	CalciumIBA 07/2013 - 03/2006
5	Cholesterol Ester Transfer ProteinsIBA 12/2008 - 01/2004
4	C-Reactive ProteinIBA 01/2019 - 08/2005
4	LDL CholesterolIBA 01/2019 - 02/2008
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2007
4	Lipoproteins (Lipoprotein)IBA 04/2017 - 10/2000
4	Apolipoproteins E (ApoE)IBA 02/2015 - 04/2001
4	Atorvastatin (Lipitor)FDA Link 06/2012 - 03/2000
3	oxidized low density lipoproteinIBA 01/2021 - 02/2008
3	Apolipoprotein E3IBA 01/2019 - 08/2005
3	Simvastatin (Zocor)FDA LinkGeneric 06/2012 - 10/2000
2	omega-Chloroacetophenone (Mace)IBA 05/2022 - 02/2008
2	Cytidine Triphosphate (CTP)IBA 01/2022 - 11/2021
2	LeptinIBA 01/2021 - 02/2016
2	AntibodiesIBA 01/2021 - 01/2018
2	Thyroid HormonesIBA 01/2020 - 09/2018
2	Glycoproteins (Glycoprotein)IBA 01/2019 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 08/2013
2	Vitamin D FDA LinkGeneric 01/2018 - 05/2014
2	Lipoprotein(a)IBA 01/2018 - 08/2006
2	CytokinesIBA 12/2013 - 04/2007
2	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2013 - 12/2013
2	Interleukin-6 (Interleukin 6)IBA 07/2013 - 04/2007
2	Phenobarbital (Luminal)FDA Link 03/2008 - 01/2008
2	ChemokinesIBA 10/2007 - 01/2007
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 03/2006 - 10/2000
2	Factor VII (Proconvertin)IBA 04/2001 - 03/2000
1	Adenosine (Adenocard)FDA LinkGeneric 11/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Phosphorylcholine (Phosphocholine)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	otamixabanIBA 11/2020
1	Hemoglobins (Hemoglobin)IBA 11/2020
1	Heparin (Liquaemin)FDA LinkGeneric 11/2020
1	Troleandomycin (TAO)FDA Link 11/2020
1	Eptifibatide (Integrilin)FDA Link 11/2020
1	DiureticsIBA 01/2020
1	boldenone undecylenate (Equipoise)IBA 09/2018
1	Thyroxine (Levothyroxine)FDA LinkGeneric 09/2018
1	Cardiolipins (Cardiolipin)IBA 01/2018
1	AlbuminsIBA 01/2018
1	Biological ProductsIBA 01/2018
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2018
1	CreatinineIBA 01/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018
1	HomocysteineIBA 01/2018
1	Complement Receptors (Complement Receptor)IBA 01/2018

Therapy/Procedure

15	Therapeutics 09/2018 - 03/2000
5	Stents 10/2018 - 04/2000
5	Percutaneous Coronary Intervention 12/2017 - 01/2007
4	Secondary Prevention 10/2017 - 07/2003
2	Drug-Eluting Stents 02/2016 - 09/2006
1	Conservative Treatment 06/2021
1	Blood Transfusion (Blood Transfusions) 11/2020
1	Liver Transplantation 06/2019
1	Lasers (Laser) 01/2018
1	Ligation 01/2018